Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

563
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
563
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

679
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
679
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

523
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
523
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

187
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
187
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

125
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings.

European heart journal. Quality of care & clinical outcomes·2025
Same author

Implementation and One-Year Evaluation of Proenkephalin A in Critical Care.

International journal of molecular sciences·2025
Same author

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.

Cardiovascular diabetology·2025
Same author

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation.

Journal of the American Heart Association·2025
Same author

The influence of anorexia nervosa on oral health and related parameters potentially relevant to orthodontic treatment: a systematic review and meta-analysis.

Clinical oral investigations·2025
Same author

Proenkephalin A 119-159 (penKid) and mortality in stable patients at high cardiovascular risk.

Clinical kidney journal·2025

Related Experiment Video

Updated: Dec 11, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.2K

[Diabetes and Heart failure].

Philipp H Baldia, Nikolaus Marx, Katharina A Schütt

    Deutsche Medizinische Wochenschrift (1946)
    |August 25, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Diabetes and heart failure significantly increase mortality risk. Effective diagnosis and treatment of both conditions are crucial for improving patient outcomes and managing this common comorbidity.

    More Related Videos

    Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
    05:58

    Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

    Published on: April 18, 2025

    482
    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
    03:42

    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

    Published on: March 29, 2024

    1.9K

    Related Experiment Videos

    Last Updated: Dec 11, 2025

    Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
    06:22

    Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

    Published on: November 29, 2024

    1.2K
    Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
    05:58

    Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

    Published on: April 18, 2025

    482
    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
    03:42

    Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

    Published on: March 29, 2024

    1.9K

    Area of Science:

    • Cardiology
    • Endocrinology
    • Internal Medicine

    Background:

    • Diabetes mellitus is a prevalent comorbidity in patients diagnosed with heart failure.
    • The co-occurrence of diabetes and heart failure leads to a substantial increase in patient mortality.
    • Optimal management necessitates a comprehensive understanding of the interplay between these two conditions.

    Purpose of the Study:

    • To provide an overview of the epidemiology of diabetes in heart failure patients.
    • To elucidate the pathogeneses underlying the combined impact of diabetes and heart failure.
    • To outline current diagnostic and therapeutic strategies for managing patients with both conditions.

    Main Methods:

    • Literature review on the epidemiology of diabetes and heart failure.
    • Analysis of pathophysiological mechanisms linking diabetes and heart failure.
    • Synthesis of current diagnostic criteria and treatment guidelines.

    Main Results:

    • The combined presence of diabetes and heart failure significantly elevates mortality rates.
    • Understanding the specific pathogeneses is key to targeted treatment.
    • Multifaceted diagnostic and therapeutic approaches are required.

    Conclusions:

    • Effective diagnosis and treatment of diabetes in heart failure patients are essential for improving prognosis.
    • Integrated management strategies are vital for reducing mortality.
    • Further research into the specific pathogeneses can optimize therapeutic interventions.